hizo lo informÓ al departamento de estado y la casa blanca y los demÓcratas aprovecharonue e pence ipymar al hijo del exvicepresidente john biden sobre el toma y daca admitiÓ que le pidiÓ a los ucranianos para las investigaciones y que el presidente de ucrania se reuniera con el presidente trump. aquÍ una parte de su exposiciÓn. (informaciÓn en pantalla) (informaciÓn en pantalla) refiriÓ a esta audiencia en particular los reporteros lo ti un viaje que tiene rumbo a texas. Él dijo que no conoce bien embajador sondland dijo que no querÍa nada con ucrania y felicidades esto continÚa maÑana la exasesora del expresidente y tambiÉn david quien tuvo una decisiÓn para republicanos y datos y no dijo hoy el embajador sondland el reporte que tenemos desde el congreso. >>> contundente declaraciones sobre todo sabiendo que sondland ha ha sidouniversal para niÑos. la defensa de los mÁs vulnerables a propÓsito de esta noche amnistÍa internacional saca a los niÑos con dignidad y respe respe respeto sin importar su situaciÓn migratoria y dejar crecer con sus familias y amigos y le pide al gobierno trum

>> ipi is under review so i don't want to get into specific details on it. we are out of time for ideas. somebody has a rebate idea that train left the station. we need solutions right here right now. this package needs to be wrapped up in the next few weeks. i spent over two years working on the rebate issue. nobody has come up with an easy solution to it. it is one of the reasons the pelosi negotiation -- it's not really a negotiation, why that thing has got to get jettisoned. not just that it has no chance of bipartisan support, it is impractical, unworkable, i don't know how it would work, it contemplates a whole new bureaucracy being created at hhs that is somehow going to divine what a drug's value should be when you've got academics, payers and drug companies and consultants all invested in figuring out how much of drug should be valued, there is no way that provision works which is why does not negotiation, it is dictating a price at the end of the day, and offer no company can refuse. the opportunity to retool that is over. the opportunity to play a

have of the executives said in the last 12 months that ipy are concerned about theft. there have been improvements. it is less of a concern than it once was. but it is still there. it is still on the list even if it has moved down slightly. looking at the soft and unofficial deadline of december 15. that is when these additional tariffs could come into place. both sides say they are communicating. ? still about agreeing on agricultural processes. david: great stuff. tom mackenzie in beijing. good to see you. my -- remind you a little bit of earlier this year when we saw the possibility of a trade deal being done? we are seeing that now with this run-up in stocks. we could be heading to a fall if we don't get something done here. >> this is definitely one of the risks that is out there. we just published our 2020 views. there are two main risks that markets need to be aware of. they are well-known and well flagged but they are certainly the ones to pay attention to. number one would be traded number two would be the u.s. election. on trade, the market has rallied quite

charles: ipi am they stupid investor because i still on the coin. >> host:: you'll be okay. [laughter] rhr rhoda i can't remember if it's in the 9010th year of an economic expansion in united states edible market. logic or history of common sense would suggest has brought a great place to be as an investor. what are your thoughts and that. charles: i happen to be, abitibi an optimist or something like myself. i say the undercurrent of the economy is really strong. i happen to be a believer the text of the women that helped our in america become internationally competitive. it was a fantastic thing. the cash flows of companies are high. even right now, reporting the most firms are report improved earnings. so consumers are in a really great position of confidence and it can go on but nonetheless the economy always markets go up and down. as a fundamental, with theirs currency or stocks or bonds, interest rates, you name it. markets will always go up and down. so if you are smart investor, understand that. in making sure you hang on the long-term and you look at any chart of l

>> like i said, ipi is under review so i don't want to get into any specific details on it. we're at a time for ideas. somebody's got a rebate idea, that train left the station. we need solutions right here, right now. this package needs to be wrapped up in the next few weeks. like i said, i spent over two years working on the rebate issue. nobody has come up with an easy solution to it. it's one of the reasons why the pelosi faux negotiation because it's not really negotiation what they're proposing on the house side, why that thing has got to get jettisoned. it's not just that it has no chance of bipartisan support, it's impractical, it's unworkable. i don't know how that thing would work. it contemplates a whole new bureaucracy at hhs somehow is going to divine what a drug's value should be. academics, payers, drug companies, consultants all invested in how much a drug should be valued. there's no way that provision works. that's why it's not negotiation, it's a price at the ends of the day, and no company could refuse. and why kill innovation. the opportunity to retool t